trending Market Intelligence /marketintelligence/en/news-insights/trending/4bAvP1WO4YXocY3DC1OkRA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

TransEnterix to restructure, explore strategic options

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

TransEnterix to restructure, explore strategic options

TransEnterix Inc. said it will explore strategic options and implement a restructuring plan to cut operating expenses.

The medical device company also revised an agreement related to the sale of its AutoLap product and intellectual property assets to Great Belief International Ltd. for $47 million.

Under the revised deal, Great Belief will no longer make a $30 million equity investment in the company. Additionally, the $17 million purchase price will now be paid in installments of $3 million, an irrevocable $13 million letter of credit by Oct. 31, and the remaining $1 million by Dec. 15.

AutoLap is an image-based scope positioning system used in laparoscopic procedures.

TransEnterix also engaged J.P. Morgan Securities LLC to assist its board in exploring strategic alternatives aimed at enhancing stockholder value. The company is considering sale, financing, strategic partnership, collaboration or other forms of commercial relationship.

There is no assurance the strategic review will lead to approval or completion of any transaction in the future, the company noted.

As of Sept. 30, the Morrisville, N.C.-based company had a total of $22.8 million in cash, cash equivalents and short-term investments. TransEnterix expects to have sufficient funds for its business operations until the first quarter of 2020.